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Summary 
p95 vav, the  product  of the  vav protooncogene,  has  been  implicated  in  the  T  cell  receptor 
(TCR)-mediated signaling cascade,  p95 ray is phosphorylated on tyrosme residues  after TCR 
stimulation by antl-TCR/CD3 antibodies and possesses  a number of landmark features of sig- 
nahng molecules such as a putative guanine nucleotide  exchange factor domain,  a pleckstrin 
homology domain, and an Src homology (SH) 2 and two SH3 domains, which provide the ca- 
pacity to form multimeric signaling complexes. However, the precise role of p95  wv in TCP,. 
signaling remains unclear. In this work we show that physiological stimulation of T  cell hybri- 
domas with antigen presented by major histocompatibility complex class I! molecules leads to a 
strong tyrosine phosphorylation of  p95 v"v and its association with tyrosane-phosphorylated SLP- 
76.  SLP-76  is a  newly described  SH2-containing protein  that has been previously found  to 
bind to the adapter molecule Grb2. Moreover, we provide evidence that p95 .... SLP-76 asso- 
ciation is SH2-mediated by demonstrating that this interaction can be inhibited by a phospho- 
peptide containing a putative p95 ....  SH2-binding motif (pYESP) present in SLP-76. Further- 
more, in vitro experiments show that after antigen stimulation, phosphorylated p95 v~v SLP-76 
can bind to Grb2 in a complex that contains pp36/38 and pp116 proteins. Our data provide a 
clue to explain recent independent  observations that overexpression of p95 v~v or SLP-76 en- 
hances TCR-mediated gene activation. 
A 
ctivation of Src and Syk family protein tyrosine kinases 
(PTKs) with subsequent phosphorylation of a number 
of cellular substrates  ranks among the  earliest events cou- 
pling the TCR  to downstream signaling pathways such as 
the Ca2+/calcineurin and R.as/Raf-1/mitogen-activated pro- 
tein (MAP)  kinases (1,  2).  Although several proteins phos- 
phorylated  on  tyrosine  after  TCP,.  triggering  have  been 
identified  (for review see reference 3),  in most cases  their 
relative position in  the  signaling cascades remains elusive. 
One of these proteins is p95 '"v (4, 5), the product of the vav 
protooncogene expressed almost exclusively in cells  of he- 
matopoietic origin (6). Mthough p95 "~v function in recep- 
tor-mediated  signaling  is  not  yet  fully  understood,  data 
from  vav-deficient  mice indicate  that  it has  a  role  in  the 
control of T  and B  cell development and activation (7-9). 
Moreover, the participation of p95 wv as a positive regulator 
of TCR-mediated  signaling  pathways  has  been  recently 
suggested by the observation that its overexpression in Jur- 
kat cells led to spontaneous activation of nuclear factor of 
activated  T  cells  (NFAT)  and  enhanced  TC1L-stimulated 
NFAT activity in a PTK-dependent manner (10,  11). 
p95 v~v contains multiple structural motifs found in intrac- 
ellular signaling molecules,  which  include  a  CDC24/Dbl 
homology regmn characteristic  of guanine  nucleotide  ex- 
change factors (GEF) as well as a pleckstrin homology do- 
main, a cystein-rich domain, and Src homology (SH) 2 and 
SH3 domains that mediate interactions among proteins and 
the formation ofmultimeric signaling complexes (6). p95 vav 
was  reported  to  display  in  vitro  guanine  nucleotide  ex- 
change  activity for  p21 r"s  after  T  and  B  cell  stimulation 
(12).  However, recent reports suggest that p95 wv acts as a 
GEF for an unidentified  member of the  Rho/R.ac  family 
rather  than  for p21 r~s  (13,  14).  Moreover,  evidence  indi- 
cates  that  p95  vav  interaction  with  other  TCR-induced 
phosphotyrosine proteins could be implicated in the regu- 
lation of its activity (15,  16).  In particular, p95 v~v has been 
described  to  interact,  via its  SH2  domain,  with  the  PTK 
ZAP-70 in TCR-stimulated Jurkat cells, possibly implicat- 
ing ZAP-70  in  the phosphorylation of p95 vav (15).  How- 
ever,  other  unidentified  phosphotyrosine  proteins  of 80 
and 74 kD were seen to copreclpitate after TC1L ligatlon, 
suggesting that they could be involved in the regulation of 
p95 vav functions. 
These studies were carried out in T  cell lines stimulated 
by anti-TCP,/CD3 antibodies. We were interested in iden- 
tiffing tyrosine-phosphorylated proteins that associate with 
p95 V~v after physiological TCP,.  recognition  of Ag-MHC 
complexes. To this end, we used murine T  cell hybridomas 
specific  for  a  tetanus  toxin  peptide  (17).  We  found  that 
stimulation by antigen presented by APC induced a strong 
tyrosine phosphorylation of p95 v~" and its association with 
tyrosine-phosphorylated  SLP-76,  a  novel  SH2  domain- 
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associated with  Grb2  in  activated T  cells  (18-20).  Addi- 
tionally, we provide evidence that p95~v-SLP-76 interac- 
tion in SH2  mediated.  These  results, together with recent 
reports  that  overexpression of p95 ~av or  SLP-76  indepen- 
dently  increased TCP,,-mediated  induction  of NFAT  and 
IL-2 promoter activity (10, 21), suggest a functional role of 
this interaction. 
Materials  and Methods 
Antibodies, Glutathione-S-Transferase (GST) Fusion Protein, and 
Peptides.  Rabbit polyclonal Ab anti-p95  ~  and antiphosphotyro- 
sine  mAb  4G10  were  purchased  from  Upstate  Biotechnology, 
Inc.  (Lake  Placid,  NY).  The  sheep  polydonal Ab  anti-SLP76 
raised against a portion (residues 136-235)  of SLP-76 as a  GST 
fusion protein was kindly provided by Dr.  G.A. Koretzky (Uni- 
versity oflowa College of Medicine, Iowa City, IA). The hamster 
mAb  145-2Cll  specific for mouse  CD3r  chain was used puri- 
fied. The following secondary Abs were used in immunoblotting: 
peroxidase conjugated goat anti-mouse (Amersham International, 
Amersham, Bucks, UK), peroxidase-conjugated goat anti-rabbit 
(Biosys, Compiegne, France), and peroxidase-conjugated donkey 
anti-sheep Abs (Sigma Chemical Co., St. Louis, MO). The GST- 
Grb2 fusion protein coupled to agarose beads was purchased from 
Santa  Cruz  Biotechnology Inc.  (Santa  Cruz,  CA).  The  tetanus 
toxin peptide tt830-843  (QYIKANSKFIGITE) and the peptide 
TSVYESPYS  corresponding  to  residues  312-320  of  human 
ZAP-70  (>95%  pure)  were  purchased  from  Neosystem  SA 
(Strasbourg, France). The tyrosine phosphorylated peptide TSVY 
(PO4)ESPYS  was  purchased  from  Chiron  Mimotopes  Peptide 
Systems (Victoria, Australia). 
Cell Lines.  The  murine  T  cell  hybridomas  T.ALI5.3  and 
T.ALS.1  expressing human  CD4  and anti-tt830-843  TCRs  re- 
stricted  to  HLA-DP,.B1*1102  were  previously  described  (17). 
The  L  cell transfectants  (L625.7)  expressing HLA-DP,  B1*1102 
(22) were kindly provided by Dr. R.W. Karr (Monsanto Chemi- 
cal Co., St. Louis, MO). 
Cell  Stimulations, lmmunoprecipitations, and  Reimmunoprecipita- 
tions.  For Ag stimulation, T  cell hybridomas (10a/ml) were in- 
cubated in suspension for 5 nfin at 37~  with L625.7 fibroblasts 
(10S/ml)  prepulsed for 3  h,  with the concentration of antigenic 
peptide tt830-843  (20  Ixg/ml) inducing maximal production of 
IL-2 (17).  For anti-CD3 stimulation, cells were incubated at 4~ 
for 30 ,nin with 145-2C 11  mAb (10  I.Lg/ml), washed, and incu- 
bated at 37~  for 5 nfin with secondary goat anti-hamster Ab (25 
ixg/ml;  Southern  Biotechnology Associates, Birmingham,  AL). 
At the end  of incubation, cells  were  harvested and lysed at  10  ~ 
cells/ml for 30 rain on ice in 1% NP-40 lysis buffer containing 20 
mM Tris-HC1, pH 7.5,  150 mM NaC1,  l  mM MgC12, and 1 mM 
EGTA in the presence ofinhibitors ofproteases and phosphatases: 
10  Ixg/ml leupeptin, 10  btg/ml aprotinm, tmM  Pefabloc-sc, 50 
mM  NaF,  10  mM  Na4P20 >  and  1 mM  NaVO4.  For peptide 
competition  experiments,  unphosphorylated  or  tyrosine-phos- 
phorylated  peptide  TSVY(PO4)ESPYS  was  added  to  the  lysis 
buffer at concentrations of 50  and  500  IxM.  Posmuclear lysates 
were obtained after centrifugation at 14,000 rpm for 10 min at 4~ 
and were precleared for 1 h with protein A- or protein G-Sepha- 
rose (Pharmacia, Uppsala, Sweden). Precleared lysates were incu- 
bated for  1 h  with  Abs preadsorbed to  protein A- or protein 
G-Sepharose beads. The reimtnunoprecipation experiments were 
performed as previously described (23). lmmunoprecipitates were 
washed twice in 1% detergent lysis buffer and twice in 0.05%  de- 
tergent lysis buffer and boiled in  SDS  sample buffer before gel 
electrophoresis. Imnmnoblotting and detection of proteins were 
performed as described (23). 
Results  and Discussion 
TCR Triggering by Ag-MHC Complexes Induces p95'"'" Ty- 
rosine Phosphorylation and Association  with  a pp75/76  Phos- 
phoprotein.  To  analyze  phosphotyrosine  modifications  of 
T  cell intracellular proteins  induced by  TCR  stimulation 
with Ag-MHC  complexes, we  used murine  T  cell hybri- 
domas  specific  for  tt830-843  peptide  presented  by  HLA- 
DI<B1*1102  molecules  expressed  on  L625.7  L  cells  (17). 
T.AL15.3  and  T.ALS.1  T  cell hybridomas  were  left  un- 
stimulated  or  added  for  5  min  to  L625.7  cells or  L625.7 
cells prepulsed for  3  h  with  an  optimal concentration  (20 
Ixg/ml)  of tt830-843  peptide.  This  peptide  concentration 
induced maximal production  of IL-2 in  both  hybridomas, 
although higher levels were found for T.ALS.1  (17). At the 
end of the incubation,  cells were  lysed in  1%  NP-40,  and 
phosphoproteins  were  analyzed on  SDS-PAGE,  followed 
by immunoblotting with antiphosphowrosine mAbs. A  3:1 
ratio ofT  cell hybridomas to L625.7  cells was used in these 
experiments to keep the background due to L625.7  cells to 
an  acceptable level (data not  shown).  As shown  in  Fig.  l, 
contact  of  T  cell  hybridomas  with  L625.7  cells  alone 
(APC)  induced  tyrosine  phosphorylation  of 95-  (pp95), 
116-  (pp116),  and  130-kD  (ppl30)  proteins,  which  in- 
creased when  the  same  cells were  stimulated in  the  pres- 
ence of the Ag (APC/Ag).  Furthermore, Ag stinmlation in- 
duced  tyrosine  phosphorylation  of  a  75/76-kD  protein 
(pp75/76),  which  migrated as a  doublet,  of a  70-kD  pro- 
tein  (pp70)  likely to  represent  ZAP-70,  as  evidenced  by 
Figure 1.  Tyrosine phosphorylation pattern ofT cell  hybridomas stim- 
ulated by Ag-MHC. NP-40  lysates from T.AL15.3 and T.AL8.1 T cell 
hybridomas unstimulated (-) or activated for 5 rain at 37~  with L625.7 
cells (APC)  or L625.7 cells  prepulsed  with the tt830-843 peptide (APC/Ag) 
or with anti-CD3 Ab (2C11)  were loaded on an 8% SDS-polyacrylamide 
gel  and  analyzed by  antiphosphotyrosine  mmmnoblotting.  Tyrosme- 
phosphorylated proteins with their relative molecular mass (in kilodaltons) 
are indicated oll the left. Position of molecular nrass lnarkers are shown in 
kilodaltons. 
1162  Interaction of p95 va" with SLP-76 Figure 2.  p95'""  is tyrosine phosphorylated  and associated with a pp75/ 
76 phosphotyrosine  protein after  TCR engagement  by Ag-MHC. Lysates 
from 107 T.AL8.1 cells unstimulated (-)  or activated for 5 rain with 
L625.7 cells (APC) or antigen-pulsed L625.7 cells (APC/Ag) were im- 
munoprecipitated (IP) with anti-p95  "~v Ab. Samples  were analyzed  on an 
8% SDS-polyacrylanfide  gel by antiphosphotyrosine  immunoblotting (A) 
or reprobed with anti-p95  wv Ab (B). 
anti-ZAP-70  immunoblotting  (data  not  shown),  and  of 
36/38-kD  protein  (pp36/38)  visible especially in  T.AL8.1 
cells.  These experiments were done using cell suspensions. 
However,  similar  results  were  obtained  when  Ag-pulsed 
adherent L625.7 cells were used, and the T  cell hybridomas 
were  rapidly detached  after stimulation  to  ensure  that  the 
observed phosphotyrosine proteins belonged to the  hybri- 
domas (data not shown). The pattern of tyrosine phosphor- 
ylation in  Ag-stimulated T.ALS.1  cells  was similar to  that 
induced by anti-CD3 antibodies (2Cll).  Nevertheless, the 
phosphorylation level of pp95  and pp75/76  in Ag-stinm- 
lated cells  was stronger when compared with that induced 
by anti-CD3 triggering, whereas the intensity of the other 
phosphoproteins remained substantially unchanged. 
Based  on  the  molecular  mass,  p95  v~v could  be  a  likely 
candidate  for  the  95-kD  protein  strongly  phosphorylated 
after Ag stimulation. To test this hypothesis and to identify 
phosphotyrosine  proteins  associated  to  p95  vav after  TCR 
stimulation, immunoprecipitates of p95  vav were analyzed in 
antiphosphotyrosine  immunoblots. As shown in  Fig.  2  A, 
unstimulated  T.AL8.1  hybridoma  showed  a  weak  basal 
level of p95  vav phosphorylation that increased after stimula- 
tion in the presence of L625.7 cells.  Tyrosine phosphoryla- 
tion of p95  vav was also observed after incubation of the TCR/ 
CD3-negative  parental  T  cell  hybridoma  580~-[3-  with 
L625.7 cells  (data not shown), suggesting that other surface 
molecules  different  from  TCR  were  responsible  for  this 
initial phosphorylation of p95  vav. Ag stimulation (Fig.  2 A) 
induced a much higher increase in the level of p95  vav phos- 
phorylation and its coprecipitation with the pp75/76  dou- 
blet observed in total lysates.  Similar results were obtained 
with T.AL15.3  cells  (data not shown).  Fig.  2  B shows the 
same blot stripped and reprobed with anti-p95 vav Ab to con- 
trol for equivalent loading of p95  v~v protein,  p95  vav could 
only come from T.AL8.1 cells, as no p95  wv was revealed by 
anti-p95  vav immunoblotting in L625.7 cells (data not shown). 
Thus,  TCR  triggering  by  Ag-MHC  molecules  induced 
the  association  of  p95  vav  with  tyrosine  phosphorylated 
pp75/76.  Although  others  have  reported  coimmunopre- 
cipitation of p95  vav with ZAP-70 in TCR stimulatedJurkat 
cells  (15),  we did not observe this association in our system 
even after longer exposure of the immunoblots. However, 
the  level  of phosphorylated  ZAP-70  (Fig.  1)  in  our  cells 
was in general weaker than in Jurkat cells (data not shown), 
perhaps explaining the failure to observe this association. 
The pp75/76 Associated with p95  va~ in Ag-stimulated T  Cell 
Hybridomas is SLP-76.  One  of several  proteins  tyrosine 
phosphorylated  in  Jurkat  cells  after  TCR  stimulation  is 
SLP-76,  an  SH2-containing  76-kD  protein  expressed ex- 
clusively in  hematopoietic  cells  (18).  Recent  data  suggest 
that SLP-76 may exert an important role in T  cell activa- 
tion (21).  SLP-76 contains a conserved tyrosine-containing 
motif (YE(S/P)P)  repeated three times in the  NH2-termi- 
nal moiety of the protein (18).  Since this motif represents a 
putative binding sequence  for the  SH2  of p95  vav (15,  24), 
SLP-76 could be a good candidate for the pp75/76  phos- 
phoprotein  interacting  with  p95  vav  in  an  SH2-mediated 
fashion.  To  test this  possibility, lysates of unstimulated  or 
Ag-activated T.ALS. 1 cells were immunoprecipitated with 
anti-p95 v~v or with  anti-mouse SLP-76 Abs. As shown in 
Fig. 3 A  (lane  6), Ag stimulation induced a strong tyrosine 
phosphorylation  of SLP-76,  which  appeared  as  a  doublet 
likely to  represent  two  phosphorylated forms of the  pro- 
tein.  Furthermore,  SLP-76  comigrated with  the  pp75/76 
phosphotyrosine doublet, which coprecipitated with p95  v~v 
after activation (Fig.  3 A, lane 3). A prolonged exposure of 
the blot corresponding to anti-SLP-76 immunoprecipitates 
from Ag-activated cells (Fig.  3 A, lane  7) revealed the pres- 
ence  of a  95-kD  phosphotyrosine  protein  with  identical 
electrophoresis  mobility  to  p95  ""v. SLP-76  was  not  de- 
tected  in  L625.7  cells  by  anti-SLP-76  immunoblotting 
(data  not  shown).  To  formally prove  the  identity  of the 
pp75/76  protein,  we  performed anti-SLP-76  reimmuno- 
precipitations  from anti-p95 ~"v precipitates  (Fig.  3  B).  In- 
deed, the pp75/76  doublet associated with p95  wv was im- 
1163  Tuosto et al.  Brief Definitive Report Fi~ee 3.  Tyrosine phosphorylated SLP-76 coprecipitates with p95  ~;'' in Ag-stimulated cells. (A) lmmunoprecipitates  with anti-p95  "~" (lanes I-3) or 
anti~SLP-76 Abs (lanes 4-7) from lysates of 10  v T.AL8.1 cells  unstimulated (-) or activated with L625.7 cells (APC) or antigen-pulsed L625.7 cells 
(APC/Ag) were analyzed  by antiphosphotyrosine immunoblotting. Films were exposed for 2 rain (lanes I-3 and 7) or 10 s (lanes 4-6). (B) Lysates  were 
p~epared from 4 ￿  107 T.ALS.  1 ceils  after stimulation with peptide-pulsed L625.7 celts (APC/Ag) and imnmnoprecipitated with anti-p95  "~" Ab. One half 
~0f the precipitates was eluted by boiling in sample buffer (lane 1), and the second half was subjected to remmmnoprecipitation by anti-SLP-76 Ab (lane 
3) after preclearmg with beads of protein G (Prot.-G, lane 2). Phosphorylated proteins were analyzed by antiphosphotyrosine immunoblotting. (C) Ly- 
sates from 10  v cells unstimulated (-) or activated with Ag-pulsed L625.7 cells (APC/Ag) were incubated with beads coupled with GST-Grb2 fusion pro- 
~ein or immure)precipitated with anti-p95  v'~ and analyzed  as in A. 
mtmoprecipitated by anti-SLP-76 antiserum (Fig. 3  B, lane 
3  vs.  lane  I).  No  tyrosine phosphorylated proteins were 
associated  with  the  control  protein  G  beads  used  in  the 
reimmunoprecipitation experiments  (Fig. 3  B,  lane 2).  Al- 
together,  these  results  indicate  that,  after  Ag  stimulation, 
p95 ..... coprecipltates with tyrosine phosphorylated SLP-76. 
The reason why p95 vav was weakly detectable in anti-SLP- 
76  precipitates could be due to the fact that the anti-SLP- 
76 antiserum was raised against a large portion of the protein, 
and it may m  part interfere with p95v~"--SLP-76 association. 
It  has  been  previously reported  that  in  both  human  T 
lymphocytes and  T  cell lines,  SLP-76  associated with  the 
SH3 domain of the adapter molecule Grb2 (18-20). A  sim- 
ilar interaction has been recently described between p95 v'~v 
and  Grb2  through  dimerization  of the  SH3  domains  of 
each of the two proteins (25). We were therefore interested 
in  verifying  whether  phosphorylated  SLP-76  interacted 
with Grb2 in Ag-stimulated T  cell hybridomas and formed 
a complex containing p95 v~v. To this end, a GST-Grb2 fu- 
sion protein was used to bind phosphoproteins from the ly- 
sate  of  unsdmulated  or  Ag-activated  T.AL8.1  cells.  As 
shown  in  Fig. 3  C,  Ag stimulation resulted in the  appear- 
ance ofphosphotyrosine proteins with molecular masses of 
116,  95,  75/76,  and 36/38  kD  that associated with  GST- 
Grb2 as previously reported (18).  In particular, the 95- and 
75/76-kD  phosphotyrosine proteins precipitated by GST- 
Grb2 possessed identical electrophoresis mobility to p95 ''~v 
and  the  associated SLP-76.  These  data are  consistent with 
reports  that  identified p95 vav and  SLP-76  as  Grb2-associ- 
ated proteins (21, 25). 
Evidence  That  the Interaction  between p95  "~ and SLP-76 Is 
SH2 Mediated.  The observation that tyrosine-phosphory- 
lated SLP-76  coprecipitated with p95 ~"v, and the  presence 
of putative binding sites for the  SH2  domain  of p95  v~ in 
SLP-76  (15,  18) suggested to us that p95 .....  SLP-76 associ- 
ation  would  be  SH2  mediated.  To  verify this  hypothesis, 
we investigated whether a tyrosine-phosphorylated peptide 
could  dissociate  the  p95  ....  SLP-76  complex  formed  in 
vivo.  The  competitor  peptide  contained  the  YESP  se- 
quence that has been described to block the interaction be- 
tween  the  SH2  domain  of p95 vav  and  ZAP-70  (15).  Ag- 
activated T  cell hybridomas were  lysed in  the  absence  or 
presence  of unphosphorylated  or  tyrosine-phosphorylated 
peptide,  and  antiphosphotyrosine  immunoblots  were  per- 
formed on p95 vav immunoprecipitates. As shown in Fig. 4 A, 
the phosphorylated (Y*ESP) but not the unphosphorylated 
(YESP) version of the p95 .....  SH2 domain competitor pep- 
tide was able to inhibit the association between p95 "~v and 
SLP-76.  A  detectable  inhibition  was  also  seen  at  10-fold 
lower  peptide  concentration  (data  not  shown).  Fig.  4  B 
shows the same blot reprobed with anti-p95  w'' antibody to 
control for the presence of equivalent quantity of p95 v~'' in all 
immunoprecipitates.  Taken  together,  these results provide 
evidence that the interaction between p95 vav and SLP-76 is 
SH2  mediated.  A  recent report by Motto  et al.  (21)  den> 
onstrated  that  the  SLP-76  SH2  domain  did  not  bind  to 
p95 v'~v, but rather to phosphoproteins of 130 and 62 kD. Ii1 
the light of these data, it is likely that after activation, p95 .... 
interacts via its SH2  domain with tyrosine-phosphorylated 
SLP-76, not vice versa. 
These  findings,  indicating that  p95 va" associates m  vivo 
with  tyrosine-phosphorylated SLP-76  after  TCR  ligation 
by  Ag-MHC  molecules,  may  contribute  toward  under- 
standing the functions of the two molecules in TCR.-medi- 
ated signaling. 
Wu et al. (10)  have demonstrated that overexpression of 
p95 v~'' in Jurkat  cells  enhanced  TCR-mediated  signaling 
leading  to  NFAT  activation,  known  to  depend  on  both 
1164  Interaction of p95  "*'' with SLP-76 Figure  4.  Inhibition  of p95~v-SLP-76 interaction by the p95"~-SH2 
domain competitor phosphopeptide. 10; T.AL8.1 cells activated for 5 min 
with Ag-pulsed L625.7 cells (APC/Ag) were lysed in the presence of 500 
~M unphosphorylated or tyrosine-phosphorylated  peptide TSVYESPYS 
(YESP); * indicates the presence of a phosphate group. Anti-p95  w~ irn- 
munoprecipitates were analyzed by 8% SDS-PAGE and immunoblotted 
with antiphosphotyrosine mAb (A) or reprobed with anti-p95  ~v Ab (B), 
Ras  and  calcineurin  pathways.  However,  the  same  report 
showed  that  p95  .... dependent  stimulation  of NFAT  was 
not  mimicked  by  activated  p21 ra~, suggesting  that  p95  wv 
may control a parallel pathway. This is consistent with data 
indicating that p95  vav is not a GEF for p2P S but rather for 
other  small  GTP-binding  proteins  such  as  Rho/Rac  (13, 
14).  In this  context it is interesting  to note that recent re- 
sults  from Genot et al.  (26)  indicate  that in T  cells  Rac-1 
can stimulate the formation ofAP-1, which is a component 
of the active NFAT complex and suggests the existence of 
pathways  parallel  to  Ras  required  for  NFAT  activation. 
The specific role of Rho in T  cells is not known, but Rho 
has  been  recently described  to  control the  integrin-medi- 
ated adhesion in leukocytes (27). Taken together, these re- 
sults  suggest  that p95  vav could activate  a  member of these 
Rho/Rac proteins and potentiate TCR-mediated signaling. 
Similarly to p95  ray, SLP-76 overexpression in Jurkat cells 
enhances TCR-mediated NFAT activity (21). It seems rea- 
sonable to hypothesize that the interaction  between p95  v~v 
and SLP-76 described here forms the basis for the observa- 
tions that both proteins independently contribute to the same 
signaling pathway. The SLP-76 sequence did not reveal the 
presence of catalytic domains (18). However, SLP-76 con- 
tains a proline-rich  region that has been recently identified 
as being responsible  for the interaction  with  the  SH3 do- 
main of Grb2 and an SH2 domain that interacts specifically 
with tyrosine phosphorylated proteins of 62 and 130 kD in 
TCR-activatedJurkat cells  (21). Moreover, a tyrosine-con- 
taining motif, likely to be involved in the interaction  with 
SH2 containing proteins, is repeated three times in SLP-76. 
Our data suggest that the tyrosine phosphorylation of these 
motifs  may  be  responsible  for  the  physical  association  of 
SLP-76  with  p95  vav after  TCR  stimulation.  Furthermore, 
using a GST-Grb2 fusion protein, we observed the forma- 
tion in vitro of a complex between Grb2 and proteins pos- 
sessing electrophoretic mobility identical to p95 vaV, SLP-76, 
and a pp36/38  protein.  The latter  has been  described as a 
membrane-bound protein that is phosphorylated after TCR 
stimulation and is able to associate with the SH2 domain of 
Grb2  (28,  29).  These  data  raise  the  interesting  possibility 
that  Grb2,  associated  via  its  SH2  domain  with  pp36/38, 
binds through the SH3 domain to SLP-76, which in turn. 
acting as an adapter,  facilitates the recruitment  of  p95  v~v to 
the  membrane,  p95  v~v may then  contribute  to  the  activa- 
tion of Rho/Rac proteins. 
Our  observations  that  an  initial  phosphorylation  of 
p95 vav was  seen  when  the  T  cell  hybridomas  were  incu- 
bated with APC in the absence of Ag and was TCR  inde- 
pendent  (data  not  shown)  suggest  that  this  event  may be 
mediated  by other  surface  receptors.  A  possible  candidate 
may be CD28,  whose stimulation by B7-1/B7-2 has been 
shown to induce p95  v~v phosphorylation (30). 
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